As current understandings of obesity (ie, a chronic disease requiring long-term management) are adopted across the world, screening and treatment can no longer follow a one-size-fits-all approach. Listen in as 3 global experts in obesity medicine highlight the emerging evidence from recent conferences that are changing real-world practice today. Learn how the latest findings apply to specific patient populations across the United States, Europe, and Asia as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors. Presenters: Stephano Del Prato, MD Professor Emeritus of Endocrinology University of Pisa Pisa, Italy Soo Lim, MD, PhD Professor of Medicine Department of Internal Medicine Seoul National University College of Medicine and Seoul National University Bundang Hospital Seoul, South Korea Donna H. Ryan, MD Professor Emerita Pennington Biomedical Research Center Louisiana State University New Orleans, Louisiana Link to full program: https://bit.ly/4pwFhEo Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Enhancing Obesity Care With Emerging Novel Therapies, Maintenance Strategies, and Individualized Priorities

Decera Clinical Education Medical Specialties Podcast

Hello, and welcome to the Decera Clinical Education Multi-Specialty Podcast. I'm your host, Jill Frost. Today's episode features three experts who highlight the emerging obesity data from recent conferences that are changing real-world practice today.

Dr. Stefano Del Prado is Professor Emeritus of Endocrinology at the University of Pisa in Italy. Dr. Sue Lam is Professor of Medicine, Department of Internal Medicine, at the Seoul National University College of Medicine in Seoul National University Budang Hospital in South Korea. And Dr. Donna A. Trine is Professor Emerita at Pennington Biomedical Research Center, Louisiana State University in the U.S.

They discuss how the latest findings in obesity studies apply to specific patient populations across the U.S., Europe, and Asia, as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors. Dr. Donna A. Trine is Professor Emeritus of Endocrinology at the University of Pisa in the U.S. This episode is part of a larger educational program titled Global Perspectives on Emerging Evidence and Obesity Management.

What's new, what's next, and what matters for primary care. For more information on Drs. Del Prado, Lam, and Ryan, along with a link to the larger education program, please visit the show notes for this episode. Now let's get started and hear what the experts have to say about this important topic. Welcome, everyone. I am Dr. Donna Ryan. It is a great pleasure to join you and Professor Del Prado. Yeah, I am Sue Lim.

And Stefano Del Prado. Thank you very much, Donna. It's also for me a great pleasure to be and to be able to join you here in this discussion. I think that we're going through a revolution now and we're talking more and more about obesity because fortunately we do have now more...

Enhancing Obesity Care With Emerging Novel Therapies, Maintenance Strategies, and Individualized Priorities

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Enhancing Obesity Care With Emerging Novel Therapies, Maintenance Strategies, and Individualized Priorities

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.